The South Korean government on Wednesday unveiled a new herbal medicine label for a new drug, which is already approved for use in a trial.
The new label says the drug “cannabis oil for treating severe fatigue and pain,” and it says the herb has been used in a “controlled, controlled trial” and it has been “tested in patients suffering from various conditions.”
The drug, called CBD-THC-THCA, is approved for the treatment of “moderate to severe fatigue, pain and anxiety” in patients with chronic pain or those suffering from chronic pain.
It was developed by the National Institute on Drug Abuse (NIDA) and the National Institutes of Health (NIH).
It was previously approved for a Phase 2 trial for patients with HIV, and has received additional FDA approval for patients suffering pain from other conditions.
The DEA approved CBD-TCA for patients who suffer from pain caused by cancer, HIV/AIDS and other medical conditions.